US 8,912,337 B2Granted

Salts and polymorphs of dexrabeprazole

AssigneeCipla Limited

InventorsDharmaraj Ramachandra Rao, Rajendra Narayanrao Kankan, Srinivas Laxminarayan Pathi, Dilip Ramdas Birari

Life of this patent

Estimating the term…

Abstract

The present invention provides dexrabeprazole magnesium hydrate and a process for its preparation. The present invention also provides a magnesium, calcium or potassium salt of dexrabeprazole, optionally in amorphous form, and processes for its preparation.

Claims22

Dependent claims

Dexrabeprazole magnesium hydrate in partially crystalline form.

Dependencies are inferred from the claim text.

Facts

Application: 13/805,235Filed 24 Jun 2011
Priority: IN 1868/MUM/201024 Jun 2010
Published: US 2013/0150588 A113 Jun 2013
Granted: 16 Dec 2014
Term ends: Not estimatedThe source records don’t support an estimate.

Classification4 codes

C07D 401/12
Containing two hetero rings: linked by a chain containing hetero atoms as chain links
A61P 1/04
Drugs for disorders of the alimentary tract or the digestive system: for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of…
C07D
Heterocyclic compounds
A61P
Therapeutic uses of medicines

Family

US 2013/0150588 A1Pre-grant publication · published 13 Jun 2013
US 8,912,337 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results